In the past two years, the FDA has fully approved two new disease-modifying treatments for Alzheimer’s — and more of these treatments are in the…
At first, scientists had no idea what might cause Alzheimer’s disease and had no underlying protein or pathway to target with treatments. Then came…
When the COVID-19 pandemic hit in 2019, researchers raised concerns it would increase the risk of neurodegenerative diseases like Alzheimer’s and Parkinson’s. A recent…
There’s a hereditary typo in Doug Whitney’s genetic code: a variant that all but guarantees its carriers will contract Alzheimer’s disease within their lifetime….
Before 1993, researchers seldom included women in clinical trials. And yet, women have dramatically different risk of health conditions than men do. For example,…
Getting an accurate Alzheimer’s diagnosis can take years — and several visits to the doctor. After taking a medical history, neurological exam, and blood tests…
Maybe you’ve heard of amyloid plaques, which build up in the brains of people with Alzheimer’s. But there’s another protein biomarker in the mix:…
A new definition of Alzheimer’s has been published — and it’s drawing a lot of criticism. According to this set of new diagnostic criteria…
If you or a loved one is going through the diagnostic process for Alzheimer’s, one of the terms you’re likely to hear quite a…
Nothing is more exciting than when my favorite basketball team, the Toronto Raptors, announced that they were signing a star player that could help…
Scientists are looking for ways to detect cognitive decline and Alzheimer’s faster, so that they can treat the disease sooner. This research involves discovering…
Anna Karenina begins with the famous line: “Happy families are all alike; every unhappy family is unhappy in its own way.” The principle holds…
In a Scottish study, the brains of beached dolphins, whales, and porpoises showed the same biomarkers as the brain of a human with Alzheimer’s….
Though Alzheimer’s disease affects more than 55 million people worldwide, there’s still no cure for the condition – and treatment options are limited. While…
The majority of Alzheimer’s research to date has been conducted in white participants. For example, the first FDA-approved anti-amyloid drug to treat Alzheimer’s, Aduhelm,…